Cytta VeriSmartPhoneTM Technology Integrates with the Oracle Cloud/IoT Platform

SAN FRANCISCO, CA / ACCESSWIRE / March 15, 2016 / Cytta Corp. (OTCPINK: CYCA) Cytta is pleased to announce they have entered into a partnership with Oracle integrating Cytta’s VeriSmartPhone(TM) technology with the Oracle Cloud/IoT platform. Cytta, and Cytta’s Healthcare Partner Doctor Direct Inc., will be utilizing Oracle Cloud/IoT functionality for all the data derived worldwide from the use of their proprietary VeriSmartPhone(TM) technology.

Cytta created the VeriSmartPhone(TM) data acquisition model over the previous six years of Research and Development and successfully demonstrated the technology with numerous field demonstrations and live medical patient remote monitoring trials.

Cytta will be utilizing Oracle software in version 2.0 of the VeriSmartPhone’s proprietary android O/S software currently being finalized. Oracle will now be supplying their Database platform including analytics, security and big data to the VeriSmartPhone(TM) model.

Cytta has also formalized their vertical market licensing model, with the completion the acquisition of the Healthcare vertical market by Doctor Direct Inc., and their ongoing rollout of the Cytta technology. Cytta’s licensing model requires an initial fee for the license, a dilutable equity interest and a Royalty in perpetuity. Cytta will supply and upgrade all the technology for their vertical market partners and supply corporate management and sales and marketing expertise as required. The Oracle Cloud/IoT Platform will also be available to any of Cytta’s partners in other vertical markets currently being negotiated.

About Cytta Corp.

Cytta Corp. is an IoT remote monitoring connectivity system and is known for its Cytta Connect open source WiFi, cellular and satellite VeriSmartPhone(TM) platform, a highly scalable and secure IoT two-way real time monitoring solution. The Cytta VeriSmartPhone(TM) technology consists of an ‘intelligent’ rooted android smartphone reprogrammed at the operating system level as an IoT control interface. This reprogrammed very smart device automatically connects all Bluetooth remote medical monitoring devices to the Oracle Cloud/IoT Platform, and from there to the designated recipients, creating two-way real time data, video and voice communication. The Cytta Connect technology automatically connects all remote monitoring devices to Oracle’s Cloud/IoT platform creating real time communication for all IoT market segments.

About Doctor Direct Inc.

The Doctor Direct medical remote monitoring technology is complete, live patient tested and has been field deployed. The Doctor Direct system is completely open source – Automatically connects any Bluetooth health or wellness devices (i.e. Blood Pressure, Blood glucose, Pulse oxygen, digital scale, etc.) to the VeriSmartPhone(TM) to the Oracle IoT/Cloud and on to the caregivers anywhere, and anytime. Data is automatically received by VeriSmartPhone(TM), interpreted, assessed and recipients determined. VeriSmartPhone(TM) transmits data in real time to the Dr., Nurse, Caregiver and/or family member along with determination of action level or importance. Dr., Nurse, caregiver, or family member responds to patient via voice, video, SMS or email in real-time through a VeriSmartPhone(TM) in the patient’s home. The Doctor Direct remote patient monitoring system, combined with the new billing/CPT codes for the service, has created the opportunity for real-time patient monitoring and a significant revenue stream to the Physician for providing better quality care.

Safe Harbor Statement/ Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks. Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will,” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise.

CONTACT INFORMATION

Cytta Corp.
Gary Campbell, CEO
Direct (702) 900 7022
Office (702) 307 1680
Email: Gary@Cytta.com
Website: www.Cytta.com

Doctor Direct Inc.
Natalia Sokolova, President
Cellular (917) 574 2312
Email: natalia@doctordirectinc.com
Website: www.DoctorDirectInc.com

Investor Relations Contact:

Complete Advisory Partners
Office: (586) 228-2290
Cell: (586) 801-9002

SOURCE: Cytta Corp.

ReleaseID: 437859